Literature DB >> 26373278

DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors.

Tali Mazor1, Aleksandr Pankov1,2, Brett E Johnson1, Chibo Hong1, Emily G Hamilton1, Robert J A Bell1, Ivan V Smirnov1, Gerald F Reis3, Joanna J Phillips1,3, Michael J Barnes3, Ahmed Idbaih4,5, Agusti Alentorn4,5, Jenneke J Kloezeman6, Martine L M Lamfers6, Andrew W Bollen3, Barry S Taylor7,8,9, Annette M Molinaro1,2, Adam B Olshen2,10, Susan M Chang1, Jun S Song2,11,12,13, Joseph F Costello1.   

Abstract

The evolutionary history of tumor cell populations can be reconstructed from patterns of genetic alterations. In contrast to stable genetic events, epigenetic states are reversible and sensitive to the microenvironment, prompting the question whether epigenetic information can similarly be used to discover tumor phylogeny. We examined the spatial and temporal dynamics of DNA methylation in a cohort of low-grade gliomas and their patient-matched recurrences. Genes transcriptionally upregulated through promoter hypomethylation during malignant progression to high-grade glioblastoma were enriched in cell cycle function, evolving in parallel with genetic alterations that deregulate the G1/S cell cycle checkpoint. Moreover, phyloepigenetic relationships robustly recapitulated phylogenetic patterns inferred from somatic mutations. These findings highlight widespread co-dependency of genetic and epigenetic events throughout brain tumor evolution.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26373278      PMCID: PMC4573399          DOI: 10.1016/j.ccell.2015.07.012

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  57 in total

1.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  p73 in Cancer.

Authors:  Alessandro Rufini; Massimiliano Agostini; Francesca Grespi; Richard Tomasini; Berna S Sayan; Maria Victoria Niklison-Chirou; Franco Conforti; Tania Velletri; Antonio Mastino; Tak W Mak; Gerry Melino; Richard A Knight
Journal:  Genes Cancer       Date:  2011-04

3.  A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.

Authors:  Chris Hunter; Raffaella Smith; Daniel P Cahill; Philip Stephens; Claire Stevens; Jon Teague; Chris Greenman; Sarah Edkins; Graham Bignell; Helen Davies; Sarah O'Meara; Adrian Parker; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Adam Butler; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; Andy Jenkinson; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; David Richardson; Rebecca Shepherd; Alexandra Small; Helen Solomon; Calli Tofts; Jennifer Varian; Sofie West; Sara Widaa; Andy Yates; Douglas F Easton; Gregory Riggins; Jennifer E Roy; Kymberly K Levine; Wolf Mueller; Tracy T Batchelor; David N Louis; Michael R Stratton; P Andrew Futreal; Richard Wooster
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

4.  Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.

Authors:  J F Costello; M S Berger; H S Huang; W K Cavenee
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

5.  Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors.

Authors:  Giuseppe Zardo; Maarit I Tiirikainen; Chibo Hong; Anjan Misra; Burt G Feuerstein; Stanislav Volik; Colin C Collins; Kathleen R Lamborn; Andrew Bollen; Daniel Pinkel; Donna G Albertson; Joseph F Costello
Journal:  Nat Genet       Date:  2002-09-30       Impact factor: 38.330

6.  IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.

Authors:  Takuya Watanabe; Sumihito Nobusawa; Paul Kleihues; Hiroko Ohgaki
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

7.  Pan-cancer patterns of DNA methylation.

Authors:  Tania Witte; Christoph Plass; Clarissa Gerhauser
Journal:  Genome Med       Date:  2014-08-30       Impact factor: 11.117

8.  Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns.

Authors:  Duncan Sproul; Robert R Kitchen; Colm E Nestor; J Michael Dixon; Andrew H Sims; David J Harrison; Bernard H Ramsahoye; Richard R Meehan
Journal:  Genome Biol       Date:  2012-10-03       Impact factor: 13.583

9.  DNA methylation profiling of human chromosomes 6, 20 and 22.

Authors:  Florian Eckhardt; Joern Lewin; Rene Cortese; Vardhman K Rakyan; John Attwood; Matthias Burger; John Burton; Tony V Cox; Rob Davies; Thomas A Down; Carolina Haefliger; Roger Horton; Kevin Howe; David K Jackson; Jan Kunde; Christoph Koenig; Jennifer Liddle; David Niblett; Thomas Otto; Roger Pettett; Stefanie Seemann; Christian Thompson; Tony West; Jane Rogers; Alex Olek; Kurt Berlin; Stephan Beck
Journal:  Nat Genet       Date:  2006-10-29       Impact factor: 38.330

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  105 in total

Review 1.  DNA-Based Biomaterials for Immunoengineering.

Authors:  Midori Maeda; Taisuke Kojima; Yang Song; Shuichi Takayama
Journal:  Adv Healthc Mater       Date:  2018-12-05       Impact factor: 9.933

Review 2.  Overcoming therapeutic resistance in glioblastoma: the way forward.

Authors:  Satoru Osuka; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

3.  Clonal evolution of glioblastoma under therapy.

Authors:  Jiguang Wang; Emanuela Cazzato; Erik Ladewig; Veronique Frattini; Daniel I S Rosenbloom; Sakellarios Zairis; Francesco Abate; Zhaoqi Liu; Oliver Elliott; Yong-Jae Shin; Jin-Ku Lee; In-Hee Lee; Woong-Yang Park; Marica Eoli; Andrew J Blumberg; Anna Lasorella; Do-Hyun Nam; Gaetano Finocchiaro; Antonio Iavarone; Raul Rabadan
Journal:  Nat Genet       Date:  2016-06-06       Impact factor: 38.330

Review 4.  Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults.

Authors:  Floris P Barthel; Kevin C Johnson; Pieter Wesseling; Roel G W Verhaak
Journal:  Neurol Clin       Date:  2018-08       Impact factor: 3.806

5.  Longitudinal genomic characterization of brain tumors for identification of therapeutic vulnerabilities.

Authors:  Eskil Eskilsson; Roel G W Verhaak
Journal:  Neuro Oncol       Date:  2016-05-28       Impact factor: 12.300

6.  Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1.

Authors:  Tali Mazor; Charles Chesnelong; Aleksandr Pankov; Llewellyn E Jalbert; Chibo Hong; Josie Hayes; Ivan V Smirnov; Roxanne Marshall; Camila F Souza; Yaoqing Shen; Pavithra Viswanath; Houtan Noushmehr; Sabrina M Ronen; Steven J M Jones; Marco A Marra; J Gregory Cairncross; Arie Perry; Sarah J Nelson; Susan M Chang; Andrew W Bollen; Annette M Molinaro; Henrik Bengtsson; Adam B Olshen; Samuel Weiss; Joanna J Phillips; H Artee Luchman; Joseph F Costello
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-15       Impact factor: 11.205

7.  Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.

Authors:  Chin-Hsing Annie Lin; Christopher T Rhodes; ChenWei Lin; Joanna J Phillips; Mitchel S Berger
Journal:  Cell Cycle       Date:  2017-02-22       Impact factor: 4.534

Review 8.  Clonal expansion in non-cancer tissues.

Authors:  Nobuyuki Kakiuchi; Seishi Ogawa
Journal:  Nat Rev Cancer       Date:  2021-02-24       Impact factor: 60.716

9.  Translating Basic Science Discoveries into Improved Outcomes for Glioblastoma.

Authors:  Peter B Dirks; Mark R Gilbert; Eric C Holland; Elizabeth A Maher; William A Weiss
Journal:  Clin Cancer Res       Date:  2020-02-14       Impact factor: 12.531

10.  Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process.

Authors:  Shigeo Ohba; Joydeep Mukherjee; Tor-Christian Johannessen; Andrew Mancini; Tracy T Chow; Matthew Wood; Lindsey Jones; Tali Mazor; Roxanne E Marshall; Pavithra Viswanath; Kyle M Walsh; Arie Perry; Robert J A Bell; Joanna J Phillips; Joseph F Costello; Sabrina M Ronen; Russell O Pieper
Journal:  Cancer Res       Date:  2016-10-06       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.